Search Results - "Parco, Claudio"

Clinical efficacy and safety outcomes of bempedoic acid for LDL-C lowering therapy in patients at high cardiovascular risk: a systematic review and meta-analysis by Lin, Yingfeng, Parco, Claudio, Karathanos, Athanasios, Krieger, Torben, Schulze, Volker, Chernyak, Nadja, Icks, Andrea, Kelm, Malte, Brockmeyer, Maximilian, Wolff, Georg

“…ObjectivesBempedoic acid (BA) is a novel oral low-density lipoprotein cholesterol lowering drug. This systematic review and meta-analysis aims to assess…”
Get full text

Risk-adjusted management in catheterization procedures for non-ST-segment elevation myocardial infarction: A standard operating procedure pilot study by Parco, Claudio, Tröstler, Jennifer, Brockmeyer, Maximilian, Hoss, Alexander, Lin, Yingfeng, Quade, Julia, Heinen, Yvonne, Schulze, Volker, Jung, Christian, Icks, Andrea, Kelm, Malte, Wolff, Georg

“…The effects of standardized risk-adjusted periprocedural management of cardiac catheterization procedures in Non-ST segment elevation myocardial infarction…”
Get full text

Robotic-assisted early mobilization and virtual reality: a perspective on innovative support strategies for critically ill patients by Parco, Claudio, Kreuels, Vanessa, Kelm, Malte, Jung, Christian, Wolff, Georg

Get full text

Validation of National Cardiovascular Data Registry risk models for mortality, bleeding and acute kidney injury in interventional cardiology at a German Heart Center by Wolff, Georg, Lin, Yingfeng, Quade, Julia, Bader, Selina, Kosejian, Lucin, Brockmeyer, Maximilian, Karathanos, Athanasios, Parco, Claudio, Krieger, Torben, Heinen, Yvonne, Perings, Stefan, Albert, Alexander, Icks, Andrea, Kelm, Malte, Schulze, Volker

“…Background and purpose The National Cardiovascular Data Registry (NCDR) risk scores for mortality, bleeding and acute kidney injury (AKI) are accurate outcome…”
Get full text

Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients by Wolff, Georg, Shamekhi, Jasmin, Al-Kassou, Baravan, Tabata, Noriaki, Parco, Claudio, Klein, Kathrin, Maier, Oliver, Sedaghat, Alexander, Polzin, Amin, Sugiura, Atsushi, Jung, Christian, Grube, Eberhard, Westenfeld, Ralf, Icks, Andrea, Zeus, Tobias, Sinning, Jan-Malte, Baldus, Stephan, Nickenig, Georg, Kelm, Malte, Veulemans, Verena

“…Background Surgical risk prediction models are routinely used to guide decision-making for transcatheter aortic valve replacement (TAVR). New and updated…”
Get full text

Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes by Wolff, Georg, Lin, Yingfeng, Akbulut, Cihan, Brockmeyer, Maximilian, Parco, Claudio, Hoss, Alexander, Sokolowski, Alexander, Westenfeld, Ralf, Kelm, Malte, Roden, Michael, Schlesinger, Sabrina, Kuss, Oliver

“…Aims Absolute treatment effects—i.e. numbers needed to treat (NNTs)—of novel antidiabetic drugs for cardiovascular outcomes have not been comprehensively…”
Get full text

Routine Glycoprotein IIb/IIIa Inhibitor Therapy in ST-Segment Elevation Myocardial Infarction: A Meta-analysis by Karathanos, Athanasios, Lin, Yingfeng, Dannenberg, Lisa, Parco, Claudio, Schulze, Volker, Brockmeyer, Maximilian, Jung, Christian, Heinen, Yvonne, Perings, Stefan, Zeymer, Uwe, Kelm, Malte, Polzin, Amin, Wolff, Georg

“…Guidelines recommend adjunct glycoprotein IIb/IIIa inhibitors (GPIs) only in selected patients with acute ST-segment elevation myocardial infarction (STEMI)…”
Get full text

Absolute treatment effects of novel antidiabetic drugs on a composite renal outcome: meta-analysis of digitalized individual patient data by Brockmeyer, Maximilian, Parco, Claudio, Vargas, Kris Gregory, Westenfeld, Ralf, Jung, Christian, Kelm, Malte, Roden, Michael, Akbulut, Cihan, Schlesinger, Sabrina, Wolff, Georg, Kuss, Oliver

“…Background Absolute treatment benefits—expressed as numbers needed to treat—of the glucose lowering and cardiovascular drugs, glucagon-like peptide-1 (GLP-1)…”
Get full text

Assessing the potential for precision medicine in body weight reduction with regard to type 2 diabetes mellitus therapies: A meta‐regression analysis of 120 randomized controlled trials by Vargas, Kris G., Rütten, Tobias, Siemes, Benedikt, Brockmeyer, Maximilian, Parco, Claudio, Hoss, Alexander, Schlesinger, Sabrina, Jung, Christian, Roden, Michael, Kelm, Malte, Wolff, Georg, Kuss, Oliver

“…Aims To assess the potential for precision medicine in type 2 diabetes by quantifying the variability of body weight as response to pharmacological treatment…”
Get full text

Process Standardization in High-Risk Coronary Interventions is Associated With Quality of Care Measures by Heinen, Yvonne, Wolff, Georg, Klein, Kathrin, Brockmeyer, Maximilian, Parco, Claudio, Perings, Stefan, Zeus, Tobias, Kelm, Malte, Icks, Andrea, Jung, Christian

“…Patient safety is one of the most important issues in healthcare. High-risk percutaneous coronary interventions (HR-PCIs) offer well-established treatment…”
Get more information

Modern NCDR and ACTION risk models outperform the GRACE model for prediction of in-hospital mortality in acute coronary syndrome in a German cohort by Parco, Claudio, Brockmeyer, Maximilian, Kosejian, Lucin, Quade, Julia, Tröstler, Jennifer, Bader, Selina, Lin, Yingfeng, Karathanos, Athanasios, Krieger, Torben, Heinen, Yvonne, Schulze, Volker, Icks, Andrea, Jung, Christian, Kelm, Malte, Wolff, Georg

“…Risk prediction with the Global Registry of Acute Coronary Events (GRACE) risk model is guideline-recommended in acute coronary syndrome (ACS) patients…”
Get full text

Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease by Brockmeyer, Maximilian, Wies, Emilia, Joerges, Jamuna, Sommer, Jana, Borgmann, Sandra Olivia, Chernyak, Nadja, Lin, Yingfeng, Parco, Claudio, Schulze, Volker, Heinen, Yvonne, Kelm, Malte, Icks, Andrea, Perings, Stefan, Wolff, Georg

“…Background/Hypothesis Risk factor control of diabetes mellitus (DM) and especially dyslipidemia remains unsatisfactory in patients with atherosclerotic…”
Get full text

National Cardiovascular Data Registry-Acute Kidney Injury (NCDR) vs. Mehran risk models for prediction of contrast-induced nephropathy and need for dialysis after coronary angiography in a German patient cohort by Parco, Claudio, Brockmeyer, Maximilian, Kosejian, Lucin, Quade, Julia, Tröstler, Jennifer, Bader, Selina, Lin, Yingfeng, Sokolowski, Alexander, Hoss, Alexander, Heinen, Yvonne, Schulze, Volker, Icks, Andrea, Jung, Christian, Kelm, Malte, Wolff, Georg

“…Background Contrast-induced nephropathy (CIN) is a major adverse event in patients undergoing coronary angiography. The Mehran risk model is the gold-standard…”
Get full text

Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials by Brockmeyer, Maximilian, Lin, Yingfeng, Parco, Claudio, Karathanos, Athanasios, Krieger, Torben, Schulze, Volker, Heinen, Yvonne, Bejinariu, Alexandru, Müller, Patrick, Makimoto, Hisaki, Kelm, Malte, Wolff, Georg

“…Periprocedural uninterrupted anticoagulation for catheter ablation of atrial fibrillation (AF) became standard after positive results of vitamin K antagonist…”
Get full text

Correction to: National Cardiovascular Data Registry-Acute Kidney Injury (NCDR) vs. Mehran risk models for prediction of contrast-induced nephropathy and need for dialysis after coronary angiography in a German patient cohort by Parco, Claudio, Brockmeyer, Maximilian, Kosejian, Lucin, Quade, Julia, Tröstler, Jennifer, Bader, Selina, Lin, Yingfeng, Sokolowski, Alexander, Hoss, Alexander, Heinen, Yvonne, Schulze, Volker, Icks, Andrea, Jung, Christian, Kelm, Malte, Wolff, Georg

Get full text